1Nakajima T, Nashimoto A, Kitamura M, et al.Adjuvant MMC and 5-FU followed by oral plus tegafur in serosa-negative gastric cancer: a randomized trial. Lancet, 1999, 354:273-277.
4Saka M, Mudan SS, Katai H, et al. Pancreaticoduodenectomy for advanced gastric Cancer. Gastric Cancer, 2005, 8: 1-5.
5Saka M, Sano T, Yamamoto S, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med, 2008, 359: 453-462.
9MacDonald JS, Smalley SR, Benedetti .I, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med, 2001, 345:725-730.
10MacDonald JS. Role of postoperative chemoradiation in resected gastric cancer. J Surg Oneol, 2005, 90: 166-170.
5Velinov N, Poptodorov G, Gabrovski N, et al. The role of matrix metalloproteinases in the tumor growth and metastasis[ J]. Khirur- giia( Sofiia), 2010,45 ( 1 ) :44-49.
6Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases : structure, function, and biochemistry [ J ]. Cire Res, 2003,92(8) :827-839.
7Yonemura Y, Fujimura T, Nishimura G, et al. Effects of intraop- erative chemohyperthermia in patients with gastric cancer with peri- toneal dissemination [ J ]. Surgery, 1996,119 ( 4 ) :437 -444.
8Watanabe H. Extracellular matrix-regulation of cancer invasion and metastasis[ J]. Gan To Kagaku Ryoho, 2010,37 ( 11 ) : 2058- 2061.
9Bourboulia D, Stetler-Stevenson WG. Matrix metalloproteinases ( MMPs ) and tissue inhibitors of metalloproteinases ( TIMPs ) : positive and negative regulators in tumor cell adhesion [ J ]. Semin Cancer Biol, 2010,20(3) :161-168.
10de Mingo M, Mor6n A, S6nchez-Pemaute A, et al. Expression of MMP-9 and TIMP-1 as prognostic markers in gastric carcinoma [J]. Hepatogastroenterology, 2007,54(73) :315-319.
